This study is in progress, not accepting new patients
Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in Chronic Hepatitis B
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Mandana Khalili
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Mandana Khalili
Chief of Clinical Hepatology, San Francisco General Hospital Director, Investigator Development Unit, Research Coordinating Center to Reduce Disparities in Multiple Chronic Diseases Co-Director, UCSF Mentor Training Program Editorial board member, Hepatology Journal My research focuses on natural history of chronic viral hepatitis (hepatitis B and hepatitis C) and cirrhosis, A…
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- ID
- NCT01369212
- Phase
- Phase 3 Hepatitis B Research Study
- Study Type
- Interventional
- Participants
- At least 201 people participating
- Last Updated